1. Home
  2. OLN vs VRDN Comparison

OLN vs VRDN Comparison

Compare OLN & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$24.70

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$28.62

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
VRDN
Founded
1892
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
OLN
VRDN
Price
$24.70
$28.62
Analyst Decision
Hold
Strong Buy
Analyst Count
14
13
Target Price
$23.43
$40.92
AVG Volume (30 Days)
2.7M
1.0M
Earning Date
04-28-2026
01-01-0001
Dividend Yield
3.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,780,800,000.00
$5,706,000.00
Revenue This Year
$1.55
$4.67
Revenue Next Year
$3.49
$331.57
P/E Ratio
N/A
N/A
Revenue Growth
3.68
N/A
52 Week Low
$17.66
$9.90
52 Week High
$27.35
$34.29

Technical Indicators

Market Signals
Indicator
OLN
VRDN
Relative Strength Index (RSI) 52.19 45.38
Support Level $22.65 $26.31
Resistance Level $26.81 $33.71
Average True Range (ATR) 1.41 1.58
MACD -0.01 0.04
Stochastic Oscillator 52.55 52.01

Price Performance

Historical Comparison
OLN
VRDN

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: